Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Dietary Ingredient Studies For Health Benefits Could Be Fenced In By US FDA IND Proposal

Dec 09 2022

• By Malcolm Spicer

• Source: Shutterstock

Related Content

Still No Appetite At US FDA For CBD In Food

Nov 22 2022

FDA Expects Closing Gap On NDI Notifications To Open Window Wider On Supplements Sold In US

Sep 23 2022

Expanded IND Guidance Threatens Supplement Research, Innovation, Stakeholders Say

Apr 23 2014

It’s Official: US Enforcement Discretion For NAC In Supplements, And Regulatory Options For FDA

Apr 21 2022

FDA Stands Firm: Clinical Trials Exploring Structure/Function Effects Need IND

Nov 03 2015

Additional Topics

International United States Dietary Supplements FDA Clinical Trials Ingredients Advertising, Marketing & Sales Business Strategies Cannabidiol CBD Commercial Compliance Consumer Enforcement Guidance Documents Manufacturing Policy Politics Regulation Retail Safety Research & Development

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window